Good Health Indicators are Not Enough: Lessons from COVID-19 in Peru

Volume 22/2, December 2020, pp 317 – 320


Camila Gianella, Ruth Iguiñiz-Romero, María José Romero, and Jasmine Gideon

Peru received international acclaim for being one of the first countries to implement a comprehensive package of measures to control the spread of the COVID-19 pandemic. The government imposed a general lockdown, combined with social protection measures—mainly cash transfers and the distribution of food parcels. This was an attempt to mitigate the impact of the lockdown, in a country where 70% of the population works in the informal sector.1 Yet despite this, the transmission rate remained high, and as of early June Peru’s COVID-19 mortality rates were amongst the highest worldwide.2 The pandemic has shed a stark light on Peru’s failure to guarantee the right to health and the limits of the tools used to assess the health system’s performance.

Over the past two decades Peru has been praised for introducing a series of reforms aimed at achieving Universal Health Coverage (UHC), primarily through the expansion of health insurance across low-income groups. Nevertheless, reforms have failed to overcome the historical fragmentation of the system, where access to services is determined by income, gender, and geographical location. Peru has focused on key health indicators, such as neonatal mortality, reduction of under-5 mortality and the prevalence of stunting, and the adoption of management systems such as contracts that prioritise health indicators included in national poverty reduction policies.3 However, the excessive focus on numerical targets rather than putting human rights at the centre of healthcare, has led to a system that overlooks significant vulnerabilities that have now been exposed, and even intensified, by COVID-19. Human rights-based imperatives, such as equality, acceptability, availability, accessibility, adaptability, and quality (known as the ‘AAAAQ’ criteria) are critical to the analysis of these vulnerabilities.

First, there are clear limitations regarding accessibility and adaptability that undermine state capacity to adequately respond to COVID-19. Despite steps towards UHC, the public system remains characterised by unequal distribution of resources and coverage between different sub-sectors of the system. The public health insurance plan (Seguro Integral de Salud—SIS) is targeted towards low-income users and it provides the lowest level of service coverage and has the least financial resourcing within the entire system.4 The deeply embedded fragmentation of the system has severely constrained the government’s response and quality of healthcare. The Ministry of Health (MoH) lacks a central information point so there is no real time information available about the level and status of equipment across the country, nor data on available beds or ventilators. Furthermore, the national prioritisation of certain health conditions and diseases, linked to global goals and national targets, has contributed to a health system that prioritises basic health packages that deliver on numerical targets. These packages provide essential care at primary health facilities, including preventive measures, such as antenatal checks, and cervical cancer and tuberculosis screening. However, a holistic approach to healthcare is missing, as is timely access to treatment, which results in poor health outcomes.5 This focus has come at the expense of capacity to test and treat for any other health conditions, including novel ones such as COVID-19.

Second, Peruvian hospitals are constrained by limited health workers and unusable essential equipment. In 2017 the Office of the Comptroller General of the Republic, the central regulator, reviewed 251 secondary and tertiary level hospitals across the country. This revealed a precarious system in which 43% of the facilities lacked sufficient health workers to function effectively. Basic pathology, such as immunological, haematological, biochemical and other tests were not being performed by 42% of hospital laboratories, and the same percentage lacked the minimum equipment necessary for sample processing, delaying patient diagnoses. These failings had not been corrected prior to the pandemic. In April 2020, 36 mechanical ventilators and oxygen plants (25% of the public sector EsSalud’s stock) were found in disrepair, contributing to the loss of many lives.6 Urgent questions must be asked as to why and how these and other essential equipment were not functioning.

Third, the COVID-19 pandemic has brought attention to deep inequalities within the system, including gender and ethnic inequalities. Despite increased health coverage, out of pocket expenditure remains high and was increasing even before the pandemic.7 Given the limited supplies of oxygen within public hospitals, relatives of COVID-19 patients have been forced to buy oxygen on the open market, paying high prices, and exacerbating the economic impact of the pandemic.

The inequalities exposed by COVID-19 draw attention to the Amazonian indigenous communities where basic sanitation conditions are limited and 60.8% lack access to a water pipeline or well.8 At the time the first COVID-19 case was reported in Lima, Amazonian regions of Loreto and Ucayali were facing a dengue outbreak that had put health services under great stress. Yet the Ministry of Health did not issue specific regional guidelines. Nor did it assess the capacity of the health system to respond to the double burden of two outbreaks, and it did not reinforce information systems, including epidemiology surveillance, making it impossible to perform a rigorous analysis of the health needs of people in these regions. Indigenous organisations produced some information showing the speed of the infection at the community level. For example, by May 22 there were 40 confirmed COVID-19 cases among indigenous communities in Ucayali. The number increased to 773 by June 16.9 Loreto and Ucayali, have the highest rates of COVID-19 (32.49% and 33.95% respectively) in the country (national average is 16.95 per cent).10

In conclusion, the early measures adopted by the Peruvian government to respond to COVID-19 must be analysed in the context of the structural shortcomings of the health system, which have been exacerbated by the pandemic. The global health agenda which prioritises progress on selected indicators, linked to global development goals, has come at the cost of a holistic, rights-based approach to healthcare in Peru. This analysis must contribute to an urgent review of the ideology that drives health indicators and is a renewed call to introduce human rights principles when designing and assessing health systems.11

Camila Gianella is Executive Director CISEPA Pontificia Universidad Católica del Perú, and Researcher Chr. Michelsen Institute, and Global Fellow, Centre on Law and Social Transformation, Norway

Ruth Iguiniz-Romero is Associate Professor, School of Public Health and Administration. Cayetano Heredia University, Peru

María José Romero is a PhD candidate, SOAS, University of London, UK and Policy and Advocacy Manager at the European Network on Debt and Development (Eurodad).

Jasmine Gideon is Senior Lecturer in Development Studies, Birkbeck, University of London, UK.


  1. Instituto Nacional de Estadística e Informática. Informe Técnico. Comportamiento de los indicadores del mercado laboral a nivel nacional. 2020.
  2. Área de Investigación e Incidencia de la Escuela de Gobierno y Políticas Públicas de la Pontificia Universidad Católica del Perú (PUCP). Datos y tendencias del Avance del COVID-19 en Perú después de 50 días del primer caso reportado y de 40 días de cuarentena [1]2020. (accessed June 11 2020).
  3. D. Cotlear and C. Vermeersch. Peruvian lessons for the transition from MDGs to SDGs. The Lancet Global Health 2016; 4(6): e353-e4; B. Alvarado and M. Mrazek. Health Outcomes and Public Health Sector Performance. In: Guigale MM, Fretes-Cibils V, Newman JL, eds. An Opportunity for a Different Peru : Prosperous, Equitable, and Governable. Washington D.C: World Bank; 2007.
  4. Ministerio de Salud. Cuentas Nacionales de Salud 1995 -2012. Lima: Ministerio de Salud; 2015.
  5. C. Gianella. Exploración de las barreras para el acceso oportuno al diagnóstico y tratamiento del cáncer de cuello uterino y de mama en el Perú y su relación con la inversión pública In: López R, Gianella C, Meza E, eds. La Otra Lucha Contra el Cancer. Lima: AIS OXFAM; 2019; L. I. Tamayo, T. Vidaurre, J. Navarro Vásquez, et al. Breast cancer subtype and survival among Indigenous American women in Peru. PLOS ONE 2018; 13(9): e0201287.
  6. Essalud. EsSalud triplicó camas UCI para pacientes COVID-19May 25, 2020. (accessed June 24 2020).
  7. P. Kanavos, G. Colville Parkin, K. Bregtje, and J. Gill. Latin America Healthcare System Overview. A comparative analysis of fiscal space in healthcare. London: LSE Consulting. London  School  of  Economics  and  Political  Science, 2019.
  8. Instituto Nacional de Estadística e Informática. Perú: Características de las viviendas particulares y los hogares. Acceso a servicios básicos , a partir de los resultados de los Censos Nacionales 2017: XII de Población, VII de Vivienda y III de Comunidades Indígenas Lima: Instituto Nacional de Estadística e Informática, 2018.
  9. ProPurus. Casos de COVID19 y Dengue en las Comunidades Nativas de Ucayali. Datos actualizados al 16 de junio del 2020. June 16 2020. (accessed June 25 2020).
  10. Ministerio de Salud. COVID-19 Sala Situacional. 2020. (accessed June 25 2020).
  11. S. Fukuda-Parr, A. E. Yamin, and J. Greenstain. Synthesis Paper – The Power of Numbers: A Critical Review of MDG Targets for Human Development and Human Rights., 2013; A. E. Yamin. Will We Take Suffering Seriously? Reflections on What Applying a Human Rights Framework to Health Means and Why We Should Care. Health and Human Rights 2008; 10(1): 45-63; A. E. Yamin and V. M. Boulanger. Why Global Goals and Indicators Matter: The Experience of Sexual and Reproductive Health and Rights in the Millennium Development Goals. Journal of Human Development and Capabilities 2014; 15(2-3): 218-31.